Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM110D | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
mRNA | HIGD1C | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | GRIK1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
mRNA | MTHFR | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | DDX28 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | GOLGA6L4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | TREX1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | ADAP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | PACS2 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | KCNK13 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |